Uxin (NASDAQ: UXIN) has been a whirlwind of price fluctuations, drawing the attention of investors looking for potential gains amidst the chaos. With a current day median price of $4.45, the stock exhibits a daily change rate of 1.84%, highlighting its dynamic nature. While analysts maintain a consensus rating of "Hold," there’s a notable divergence in price targets, with estimates ranging from a low of $2.57 to a high of $3.13. This volatility can present unique opportunities for those willing to navigate the ups and downs. As Uxin continues to operate in the competitive auto and truck dealership industry, savvy investors may find that this unpredictability could lead to advantageous trading moments. Uxin is currently expected to deliver daily returns of 2.12%, with a risk level of 13.52% over the next 90 days. As traditional traders steer clear of the specialty retail sector, it’s worth taking a closer look at Uxin to grasp its current volatility trends. We’ll assess whether the recent fluctuations in Uxin’s stock price indicate a potential rebound this October.
Uxin operates in the Specialty Retail sector and falls under the Consumer Discretionary industry. The company has a performance score of 12 out of 100. With a beta of 0.56, Uxin may offer some diversification benefits in a portfolio. This means that when the market rises, Uxin's returns are likely to increase at a slower pace. Conversely, during market downturns, losses from holding Uxin are expected to be less severe. To evaluate Uxin's potential future returns, consider using its semi-variance, along with the relationship between its Treynor ratio and daily balance of power. These metrics can provide valuable insights into the stock's performance.
Top Findings
Uxin (NASDAQ: UXIN) continues to exhibit significant volatility, with a standard deviation of 13.21, making it a noteworthy consideration for those looking to capitalize on price fluctuations. The stock has seen a maximum drawdown of 62.35, indicating substantial risk but also the potential for high rewards. Savvy investors might find the current quote of 5.2 appealing, especially given the stock's recent price momentum of 2.37.Uxin
financial leverage refers to using borrowed capital as a funding source to finance Uxin ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Uxin financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Uxin's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Uxin's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Uxin's total debt and its cash.
The recent price roll up of Uxin created some momentum for investors as it was traded today as low as
2.92 and as high as
5.97 per share. The company executives may have good odds in positioning the company resources to exploit market volatility in
October. The stock standard deviation of daily returns for 90 days investing horizon is currently 13.52. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Uxin partners.
In the world of investing, high volatility often brings both risk and opportunity. Uxin (NASDAQ: UXIN) has recently demonstrated significant fluctuations, with a coefficient of variation of 653.19, highlighting its unpredictable nature. With cash and equivalents totaling $88.19 million against a hefty total debt of $370.13 million, the company faces challenges, yet this volatility could present savvy investors with a chance to capitalize on price movements. The stock currently trades around $4.70, with a target price of $11.21, suggesting a potential upside of 19.15%. However, investors should remain cautious, as the probability of bankruptcy stands alarmingly high at 96%..
Can Uxin build up on the recent roll up?
Uxin's stock has recently shown signs of stability, with its standard deviation dropping to 13.21. This decrease in price fluctuations suggests that the stock may be gaining traction after a recent upward trend. If Uxin can keep this momentum going, it could attract more investors seeking a dependable opportunity, potentially leading to further gains. The key question is whether the company can capitalize on this stability to enhance its growth.
However, Uxin still exhibits above-average volatility over the selected period. Understanding market volatility can help investors time their moves effectively.
By using volatility indicators, traders can assess Uxin's risk compared to overall market trends. Increased volatility during bear markets can negatively affect Uxin's stock price, causing stress for investors as they watch their investments decline. This often leads to portfolio rebalancing as they seek to mitigate losses.As October unfolds, Uxin presents a mixed bag for potential investors. With an analyst consensus rating of "Hold," the stock is currently valued at around
5.2, while its real value is estimated at
3.3. This suggests that while there may be some upside, caution is warranted. The highest target price set by analysts is
3.13, indicating limited growth potential in the near term. Investors should weigh these insights carefully, considering both the market dynamics and their own risk tolerance before making any decisions..
Gabriel Shpitalnik is a Member of Macroaxis Editorial Board. Gabriel is a young entrepreneur and writes predominantly on the business, technology, and finance sector. He likes to analyze different equity instruments across a wide range of industries focusing primarily on consumer products and evolving technologies.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Uxin. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com